Strata Critical Medical (SRTA) EBITDA Margin (2020 - 2026)
Strata Critical Medical (SRTA) posted quarterly EBITDA Margin of 4.41% for Q1 2026, up 1140.0% year-over-year from 0.36% in Q1 2025, and up 53.98% quarter-over-quarter from 9.59% in Q4 2025.
Strata Critical Medical (SRTA) EBITDA Margin (2020 - 2026) Analysis & Trends
Strata Critical Medical (SRTA) has reported EBITDA Margin for 7 consecutive years, with 4.41% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 1140.0% year-over-year to 4.41%; the TTM figure through Mar 2026 stood at 7.85% (up 964.0% YoY), while the FY2025 annual figure was 11.34%, up 400.0% from the prior year.
- EBITDA Margin grew to 4.41% in Q1 2026 per SRTA's latest filing, from 9.59% in the prior quarter.
- Across five years, EBITDA Margin topped out at 4.41% in Q1 2026 and bottomed at 75.05% in Q4 2023.
- Historically, EBITDA Margin has averaged 22.93% across 5 years, with a median of 17.88% in 2024.
- On a YoY basis, EBITDA Margin climbed as much as 5883 bps in 2024 and fell as far as 924 bps in 2024.
- Strata Critical Medical's EBITDA Margin stood at 37.62% in 2022, then plunged by 100 bps to 75.05% in 2023, then soared by 78 bps to 16.23% in 2024, then jumped by 41 bps to 9.59% in 2025, then surged by 54 bps to 4.41% in 2026.
- Business Quant data shows SRTA's EBITDA Margin at 4.41% in Q1 2026, 9.59% in Q4 2025, and 11.4% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -12.60% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 26.67% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 2.10% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 16.29% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 8.50% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 11.14% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 7.66% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 13.25% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 18.99% |
| 10 | Strata Critical Medical | 521.95 Mn | 499.20 Mn | 15.22 Mn | -7.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.46% |
| Mar 31, 2026 | -4.41% |
| Dec 31, 2025 | -9.59% |
| Sep 30, 2025 | -11.40% |
| Jun 30, 2025 | -7.00% |
| Mar 31, 2025 | -15.81% |
| Dec 31, 2024 | -16.23% |
| Sep 30, 2024 | -19.67% |
| Jun 30, 2024 | -17.88% |
| Mar 31, 2024 | -19.16% |
| Dec 31, 2023 | -75.05% |
| Sep 30, 2023 | -10.43% |
| Jun 30, 2023 | -20.02% |
| Mar 31, 2023 | -28.33% |
| Jun 30, 2022 | -37.62% |
| Mar 31, 2022 | -51.41% |
| Sep 30, 2021 | -51.07% |
| Jun 30, 2021 | -47.55% |
| Mar 31, 2021 | -45.56% |
| Jun 30, 2020 | -42.93% |